Polypharma celebrates 30th Anniversary

Single partner Polypharma offers a unique blend of services and skills that make it possible for it to act as a single partner accompanying local companies all the way from selection of target product through to actual receipt of raw materials for production. “Over...

High concentration drugs now injectable

The researchers designed a system that made it possible to inject highly concentrated drug formulations subcutaneously while reducing the required injection force, which exceeded what is possible with manual subcutaneous injection using a conventional...

Bempedoic acid inhibit cholesterol biosynthesis

Bempedoic acid is a new class of nonstatin LDL-lowering therapy that has been approved for the European market since April 2020. Bempedoic acid can be used as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous...

EMA Approval Recommendations

At its July 2020 meeting, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of eleven medicines: 3 new anticancer drugs 1 Janus kinase inhibitor for rheumatoid arthritis 1 antibody for sickle-cell...

New oral formulation with Diclofenac

In France, 50 mg of diclofenac epolamine granules for oral suspension in sachets have been granted marketing authorisation and are now available. The field of application extends over: short-term symptomatic treatment of acute seizures of extraarticular rheumatism...

Carbon-hydrogen bonds can now also be functionalised

After almost 25 years of work, chemists at the University of Berkeley have now succeeded in opening the least reactive C-H bonds using a newly developed catalyst and replacing them with a boron compound. Because the primary C-H bond of the terminal methyl group (CH3)...